The impact of PD1 and PDL1 immunotherapy on non-small cell lung cancer outcomes: a systematic review

Shivani Kanabar, Abhinav Tiwari , Vina Soran, Prashanthan Balendran, Malcolm Price, Alice Turner

Research output: Contribution to journal › Article › peer-review

Not yet published as of 17/05/2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

KanabarSS2022impact
Accepted author manuscript, 7.09 MB
Licence: Creative Commons: Attribution-NonCommercial (CC BY-NC)
Embargo ends: 15/06/22

@article{b91e5797fc3a4a66b40484edef90e22c,

title = "The impact of PD1 and PDL1 immunotherapy on non-small cell lung cancer outcomes: a systematic review",

author = "Shivani Kanabar and Abhinav Tiwari and Vina Soran and Prashanthan Balendran and Malcolm Price and Alice Turner",

note = "Not yet published as of 17/05/2022",

year = "2022",

month = may,

day = "13",

language = "English",

journal = "Thorax",

issn = "0040-6376",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - The impact of PD1 and PDL1 immunotherapy on non-small cell lung cancer outcomes

T2 - a systematic review

AU - Kanabar, Shivani

AU - Tiwari , Abhinav

AU - Soran, Vina

AU - Balendran, Prashanthan

AU - Price, Malcolm

AU - Turner, Alice

N1 - Not yet published as of 17/05/2022

PY - 2022/5/13

Y1 - 2022/5/13

UR - https://thorax.bmj.com/

M3 - Article

JO - Thorax

JF - Thorax

SN - 0040-6376

ER -